Edition:
United Kingdom

Sienna Biopharmaceuticals reports third quarter results


Thursday, 8 Nov 2018 

Nov 8 (Reuters) - Sienna Biopharmaceuticals Inc ::SIENNA BIOPHARMACEUTICALS® REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.SIENNA BIOPHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE $0.82.SIENNA BIOPHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS AS OF SEPT. 30, 2018, TOTALED APPROXIMATELY $64.0 MILLION.